This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Wistuba, I. I. Articles by Gazdar, A. F. Search for Related Content PubMed PubMed Citation Articles by Wistuba, I. I. Articles by Gazdar, A. F.

Distinct K-ras Mutation Pattern Characterizes Signet Ring Cell Colorectal Carcinoma¹

Departments of Anatomic Pathology [I. I. W.] and Surgery [F. L.], Pontificia Universidad Catolica de Chile, Santiago, Chile, and Hamon Center for Therapeutic Oncology Research [C. B., A. F. G.] and Department of Pathology [R. D., J. A. S.], University of Texas Southwestern Medical Center, Dallas, Texas 75390

Purpose: Signet ring cell colorectal carcinoma (SRCCC) represents a unique, infrequent, and highly malignant variant of colorectal cancer. To understand the pathogenesis of SRCCC, we investigated its molecular abnormalities and compared them with those of the usual type of colorectal adenocarcinoma.

Experimental Design: Microdissected archival paraffin-embedded tissue from 16 SRCCCs and 27 non-SRCCCs was used to determine the frequency and pattern of mutation at codons 12, 13, and 61 of K-ras. A subset of tumors was examined for TP53 mutations at exons 5–8 and allele loss and genetic instability using seven microsatellite and two mononucleotide markers.

Results: Comparable data on TP53 mutation, allele loss, and microsatellite instability were found between SRCCC and non-SRCCC. However, SRCCCs demonstrated a distinct pattern of K-ras mutation with a significantly lower frequency of mutations at codons 12 and 13 (13% versus 48%, P = 0.02) as compared with the non-SRCCCs. Four cases (25%) of SRCCC demonstrated the same A:T transversion at the third base position of K-ras codon 61 (CAA to CAT; Gln to His). No such point mutation was detected in non-SRCCCs or in the 30 gastric and 4 urinary bladder signet ring cell carcinomas examined.

Conclusions: Our findings suggest that a distinct pattern of K-ras mutation is present in SRCCC, including a specific codon 61 mutation that has rarely been reported in human neoplasms.